MA
TNDM icon

MCF Advisors’s Tandem Diabetes Care TNDM Stock Holding History

MCF Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-223
Closed -$8.03K – 1016
2024
Q4 		$8.03K Sell
223
-868
-80% -$29.4K ﹤0.01% 698
2024
Q3 		$46.3K Buy
1,091
+85
+8% +$3.6K ﹤0.01% 407
2024
Q2 		$40.5K Hold
1,006
– – ﹤0.01% 423
2024
Q1 		$35.6K Buy
1,006
+445
+79% +$11.9K ﹤0.01% 431
2023
Q4 		$16.6K Buy
561
+461
+461% +$9.56K ﹤0.01% 535
2023
Q3 		$2.08K Hold
100
– – ﹤0.01% 763
2023
Q2 		$2.45K Buy
+100
New +$3.22K ﹤0.01% 691

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCF Advisors's TNDM Position: Q1 2025 in Review

MCF Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 223 shares — an estimated $8.03K sold.

MCF Advisors first reported a position in TNDM in Q2 2023 and held it in 7 quarters. The position peaked at $46.3K in Q3 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • MCF Advisors reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • MCF Advisors sold 223 Tandem Diabetes Care shares in Q1 2025, an estimated $8.03K.
  • MCF Advisors first reported a position in Tandem Diabetes Care in Q2 2023 and held it in 7 quarters.
  • MCF Advisors's Tandem Diabetes Care position peaked at $46.3K in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on MCF Advisors's 13F filing for Q1 2025, filed 6 May 2025.